Article
Genome editing of HBG1 and HBG2 to induce fetal hemoglobin.
Blood advances - 12 Nov 2019
Métais Jean-Yves, Doerfler Phillip A, Mayuranathan Thiyagaraj, Bauer Daniel E, Fowler Stephanie C, Hsieh Matthew M, Katta Varun, Keriwala Sagar, Lazzarotto Cicera R, Luk Kevin, Neel Michael D, Perry S Scott, Peters Samuel T, Porter Shaina N, Ryu Byoung Y, Sharma Akshay, Shea Devlin, Tisdale John F, Uchida Naoya, Wolfe Scot A, Woodard Kaitly J, Wu Yuxuan, Yao Yu, Zeng Jing, Pruett-Miller Shondra, Tsai Shengdar Q, Weiss Mitchell J
Abstract excerpt
Induction of fetal hemoglobin (HbF) via clustered regularly interspaced short palindromic repeats/Cas9-mediated disruption of DNA regulatory elements that repress γ-globin gene (HBG1 and HBG2) expression is a promising therapeutic strategy for sickle cell disease (SCD) and β-thalassemia, although the optimal technical approaches and limiting toxicities are not yet fully defined. We disrupted an HBG1/HBG2 gene...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
